MedTrace Logo

Changes in Blood Lipids After Long-term Consumption of n-3 LC-PUFA-Enriched Dairy Products

NCT00639041 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2011-09-22

No results posted yet for this study

Summary

The study was performed to investigate the effects of n-3 LC-PUFA supplemented dairy products cardiovascular risk factors in hypertriglyceridemic patients.

Conditions

  • Hypertriglyceridemia

Interventions

DIETARY_SUPPLEMENT

n-3 LC-PUFA

n-3 LC-PUFA supplemented dairy products (yoghurt, cheese, butter): 3.3 g n-3 FA/d

DIETARY_SUPPLEMENT

Placebo

dairy products without special oils

Sponsors & Collaborators

  • University of Jena

    lead OTHER

Principal Investigators

  • Gerhard Jahreis, Prof. Dr. · University of Jena, Dept. of Nutritional Physiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
43 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00639041 on ClinicalTrials.gov